Beijing Sun Novo Pharmaceutical Research Co Ltd Cash Flow Reinvestment Rate

Latest as of September 2025: 0.06x

Beijing Sun Novo Pharmaceutical Research Co Ltd cash flow reinvestment rate. Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) has a Cash Flow Reinvestment Rate of 0.06x as of September 2025, reinvesting CN¥4.69 Million (capex CN¥4.69 Million ) from operating cash flow of CN¥76.07 Million. Explore Beijing Sun Novo Pharmaceutical Research (688621) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.06x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥4.69 Million
Capex + Investments

Operating Cash Flow

CN¥76.07 Million
CNY

Capital Expenditures

CN¥4.69 Million
CNY

Cash Flow Reinvestment Rate of Beijing Sun Novo Pharmaceutical Research Co Ltd (2017–2025)

Cash flow reinvestment rate of Beijing Sun Novo Pharmaceutical Research Co Ltd from 2017 to 2025. Historical reinvestment intensity for Beijing Sun Novo Pharmaceutical Research Co Ltd across 9 annual periods. Explore 688621 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Beijing Sun Novo Pharmaceutical Research Co Ltd Cash Flow Reinvestment Rate by Year (2017–2025)

Beijing Sun Novo Pharmaceutical Research Co Ltd cash flow reinvestment rate by year from 2017 to 2025. Year-by-year capital reinvestment analysis for Beijing Sun Novo Pharmaceutical Research Co Ltd. For the full cash flow conversion analysis, see Beijing Sun Novo Pharmaceutical Research operating cash flow efficiency.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 2.22x CN¥206.80 Million CN¥93.21 Million CN¥42.43 Million ▲ +5.0%
2024 2.11x CN¥67.63 Million CN¥32.02 Million CN¥30.48 Million ▲ +21.4%
2023 1.74x CN¥161.62 Million CN¥92.86 Million CN¥72.96 Million ▲ +56.8%
2022 1.11x CN¥115.37 Million CN¥103.96 Million CN¥103.87 Million ▼ -72.9%
2021 4.09x CN¥360.74 Million CN¥88.25 Million CN¥84.96 Million ▲ +310.5%
2020 1.00x CN¥62.74 Million CN¥62.99 Million CN¥27.03 Million ▲ +39.0%
2019 0.72x CN¥40.83 Million CN¥56.97 Million CN¥25.67 Million ▲ +92.6%
2018 0.37x CN¥16.41 Million CN¥44.11 Million CN¥16.41 Million ▼ -85.8%
2017 2.62x CN¥20.96 Million CN¥8.01 Million CN¥20.96 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow